ESMO 2017 Congress

Oncology Meeting Resources

08 Sep - 12 Sep 2017, Madrid, Spain

ESMO-2017-square

The ESMO 2017 Congress, in partnership with the European Association for Cancer Research (EACR), will bring cancer researchers and clinicians together to enable collaboration and the exchange of ideas, from the laboratory to the bedside and back.
Presentations (slides) and webcasts are available to ESMO members according to the presenters' agreement to release them. Abstracts are open access. Congress attendees should access via the ESMO Conferences platform.
The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programmeFuture ESMO meetings

Watch the ESMO scientific videos!

Special Sessions and Tracks





Format available

https://oncologypro.esmo.org/Meeting-Resour...O-2017-Congress/EACR-2017-Scientific-Address

Date: 08 Sep 2017
Presenter: Richard Marais
Resources: Webcast

https://oncologypro.esmo.org/Meeting-Resour...7-Congress/Presentation-of-the-ESMO-Award-by

Date: 08 Sep 2017
Presenter: Christoph Zielinski
Resources: Webcast

https://oncologypro.esmo.org/Meeting-Resour...-lecture-Oncology-The-importance-of-teamwork

Date: 08 Sep 2017
Presenter: Miguel Martin Jimenez
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...-of-the-ESMO-Translational-Research-Award-by

Date: 08 Sep 2017
Presenter: Christoph Zielinski
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...ng-and-targeting-colorectal-cancer-evolution

Date: 08 Sep 2017
Presenter: Alberto Bardelli

https://oncologypro.esmo.org/Meeting-Resour...on-of-the-ESMO-Lifetime-Achievement-Award-by

Date: 08 Sep 2017
Presenter: Christoph Zielinski
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...ress/ESMO-Lifetime-Achievement-Award-lecture

Date: 08 Sep 2017
Presenter: José Baselga
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...ancer.-Results-of-the-UNICANCER-NeoPAL-study

BackgroundBenefit of neoadjuvant chemotherapy in patients (pts) with luminal breast cancer (LBC) is limited. Palbociclib combined with endocrine treatment has shown impressive results in advanced LBC.

Date: 08 Sep 2017
Presenter: paul cottu
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer, Early Stage, Breast Cancer, Prostate Cancer

https://oncologypro.esmo.org/Meeting-Resour...ith-ER-HER2-negative-early-breast-cancer-EBC

BackgroundTaselisib is an oral, potent, and selective PI3-kinase (PI3K) inhibitor with enhanced activity against PIK3CA mutant (MUT) cancer cells. Confirmed partial responses were observed in pts with...

Date: 08 Sep 2017
Presenter: Cristina Saura
Resources: Abstract, Presentation
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer, Early Stage, Breast Cancer, Prostate Cancer

https://oncologypro.esmo.org/Meeting-Resour...-FLOT4-AIO-trial-German-Gastric-Group-at-AIO

BackgroundFLOT4 is the first study to show improvement of outcome over another well-established bimodality therapy in patients with esophagogastric cancer. To consolidate initial results, we performed...

Date: 08 Sep 2017
Presenter: Salah-Eddin Al-Batran
Resources: Abstract, Presentation, Webcast
Topics: Oesophageal Cancer, Gastric Cancer, Gastrointestinal Cancers